We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
FDA Recalls Textured Breast Implants Because of Lymphoma Risk.
- Abstract
The article reports on the request of the U.S. Food and Drug Administration for pharmaceutical firm Allergan to recall its BIOCELL textured breast implants and tissue expanders. Topics mentioned include the risk of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), the possibility of BIA-ALCL when treating a patient with late onset, peri-implant changes, and development of an individualized treatment plan considering current clinical practice guidelines.
- Subjects
LYMPHOMA risk factors; BREAST implants; LYMPHOMAS; PATIENT education; PHARMACEUTICAL industry; PRODUCT recall; UNITED States. Food &; Drug Administration; OCCUPATIONAL roles; SYMPTOMS
- Publication
ONS Voice, 2019, Vol 34, Issue 9, p43
- ISSN
2475-6938
- Publication type
Article